المؤلفون: João Pedro Ferreira, Leong L. Ng, Chim C. Lang, Nicolas Girerd, Wouter Ouwerkerk, Kevin Duarte, Marco Metra, Gerasimos Filippatos, Patrick Rossignol, Kenneth Dickstein, Faiez Zannad, Adriaan A. Voors, Masatake Kobayashi, Dirk J. van Veldhuisen

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), University Medical Center Groningen [Groningen] (UMCG), National Heart Centre Singapore (NHCS), University of Amsterdam [Amsterdam] (UvA), Civic Hospital of Brescia, Ninewells Hospital and Medical School [Dundee], University of Dundee, University Hospitals Leicester, Attikon University Hospital, National and Kapodistrian University of Athens (NKUA), University of Bergen (UiB), Stavanger University Hospital, BIOSTAT-CHF was funded by the European Commission (FP7-242209-BIOSTAT-CHF). Further financial support was provided by Roche diagnostics. João Pedro Ferreira, Nicolas Girerd, Patrick Rossignol, Faiez Zannad are supported by the French National Research Agency Fighting Heart Failure (ANR-15-RHU-0004), by the French PIA project 'Lorraine Université d'Excellence' GEENAGE (ANR-15-IDEX-04-LUE) programmes, and the Contrat de Plan Etat Région Lorraine and FEDER IT2MP., ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE,Isite LUE(2015), European Project: 242209,EC:FP7:HEALTH,FP7-HEALTH-2009-single-stage,BIOSTAT-CHF(2010), Epidemiology and Data Science, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular Centre (CVC)

المصدر: Clinical Cardiology
Clinical Cardiology, Wiley, 2021, ⟨10.1002/clc.23576⟩
Clinical cardiology, 44(6), 780-788. Wiley-Blackwell
Clinical Cardiology, 44(6). Wiley

مصطلحات موضوعية: Hyperkalemia, beta‐, beta‐blocker, treatment up‐titration, Angiotensin-Converting Enzyme Inhibitors, 030204 cardiovascular system & hematology, GUIDELINES, HYPERKALEMIA, 0302 clinical medicine, ACE‐, Medicine, 030212 general & internal medicine, ACE-inhibitor, ELDERLY-PATIENTS, OUTCOMES, Ejection fraction, treatment up-titration, General Medicine, ARB, treatment up‐, EUROPEAN-SOCIETY, 3. Good health, inhibitor, Cardiology, beta-blocker, medicine.symptom, Cardiology and Cardiovascular Medicine, medicine.drug, Bradycardia, titration, medicine.medical_specialty, adverse effects, Angiotensin Receptor Antagonists, Biology, Humans, Stroke Volume, Heart Failure, medicine.drug_class, Clinical Investigations, CONVERTING ENZYME-INHIBITOR, ACE‐inhibitor, LISINOPRIL, 03 medical and health sciences, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Heart rate, cardiovascular diseases, blocker, Adverse effect, Beta blocker, business.industry, medicine.disease, WORSENING RENAL-FUNCTION, EFFICACY, Heart failure, ACE inhibitor, SYSTOLIC DYSFUNCTION, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99989c71666f71094b5f832d66ce8d24Test
http://www.scopus.com/inward/record.url?scp=85105667247&partnerID=8YFLogxKTest

المؤلفون: Javed Butler, Milton Packer, Gerasimos Filippatos, Joao Pedro Ferreira, Cordula Zeller, Janet Schnee, Martina Brueckmann, Stuart J Pocock, Faiez Zannad, Stefan D Anker

المساهمون: BOZEC, Erwan, University of Mississippi Medical Center (UMMC), Baylor Heart and Vascular Institute, Baylor Jack and Jane Hamilton, National and Kapodistrian University of Athens (NKUA), Université d'Athènes (UOA), Attikon University Hospital, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Boehringer Ingelheim International GmbH, University of Heidelberg, Medical Faculty, London School of Hygiene and Tropical Medicine (LSHTM), Berlin-Brandenburg Center for Regenerative Medicine [Berlin, Germany] (BCRT), Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Funding for the EMPEROR trials was provided by Boehringer Ingelheim and Eli Lilly and Company., Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)

المصدر: European Heart Journal
European Heart Journal, Oxford University Press (OUP), 2021, pp.ehab798. ⟨10.1093/eurheartj/ehab798⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2021, pp.ehab798. ⟨10.1093/eurheartj/ehab798⟩

مصطلحات موضوعية: Ejection fraction, animal structures, Empagliflozin, Stroke Volume, Heart failure, 030204 cardiovascular system & hematology, Ventricular Function, Left, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, Hospitalization, 03 medical and health sciences, 0302 clinical medicine, Glucosides, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Humans, Sex, 030212 general & internal medicine, Benzhydryl Compounds, Cardiology and Cardiovascular Medicine

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7717b89c37c105ce6805920b14517362Test
https://doi.org/10.1093/eurheartj/ehab798Test

المؤلفون: Subodh Verma, Milton Packer, Stefan D. Anker, Carolyn S.P. Lam, Daniel Cotton, Stuart J. Pocock, Martina Brueckmann, David Sim, Janet Schnee, Javed Butler, Egon Pfarr, Gerasimos Filippatos, João Pedro Ferreira, Hiroyuki Tsutsui, Faiez Zannad, Naveed Sattar

المساهمون: Cardiovascular Centre (CVC), National Heart Centre Singapore (NHCS), University Medical Center Groningen [Groningen] (UMCG), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Boehringer Ingelheim International GmbH, Department of Cardiovascular Medicine, Kyushu University, Higashi-ku, Kyushu University [Fukuoka], Berlin-Brandenburg Center for Regenerative Therapies [Berlin, Germany], Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Mississippi State University [Mississippi], Attikon University Hospital, National and Kapodistrian University of Athens (NKUA), London School of Hygiene and Tropical Medicine (LSHTM), Institute of Cardiovascular and Medical Sciences [Glasgow], University of Glasgow, St. Michael's Hospital, University of Toronto, University of Heidelberg, Medical Faculty, Boehringer Ingelheim Pharmaceuticals, Inc, Baylor University Medical Center, Baylor College of Medecine, Imperial College London, The EMPEROR-Reduced trial was funded by Boehringer Ingelheim and Eli Lilly (EMPEROR-Reduced ClinicalTrials.gov number, NCT03057977)

المصدر: European Heart Journal, 42(43), 4442-4451. Oxford University Press
European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2021, pp.ehab360. ⟨10.1093/eurheartj/ehab360⟩

مصطلحات موضوعية: Relative risk reduction, Ethnic group, Empagliflozin, Fast Track Clinical Research, Heart failure, 030204 cardiovascular system & hematology, Placebo, Racial differences, 03 medical and health sciences, 0302 clinical medicine, Primary outcome, Glucosides, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Ethnicity, Medicine, Humans, In patient, AcademicSubjects/MED00200, 030212 general & internal medicine, Benzhydryl Compounds, 10. No inequality, Heart Failure and Cardiomyopathies, Ejection fraction, business.industry, Geographic differences, Stroke Volume, medicine.disease, 3. Good health, Cardiology and Cardiovascular Medicine, business, Demography

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23bb2525fec17c55d216445b7fa338a3Test
https://doi.org/10.1093/eurheartj/ehab360Test

المؤلفون: Anne G. Raafs, Christian Delles, Andrew L. Clark, Arantxa González, Nicolas Vodovar, Timothy Collier, Michiel T H M Henkens, Jan A. Staessen, Javier Díez, Alessandro Boccanelli, João Pedro Ferreira, Florence Pinet, Ping Wang, Patrick Rossignol, Mark R. Hazebroek, Vanessa P. M. van Empel, John G.F. Cleland, Faiez Zannad, J. Wouter Jukema, Rudolf A. de Boer, Jens Björkman, Nicolas Girerd, Thomas Thum, Stephane Heymans, Job Verdonschot

المساهمون: Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], Cardiovascular Research Institute Maastricht (CARIM), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), London School of Hygiene and Tropical Medicine (LSHTM), TATAA Biocenter AB, Casa di Cura Quisisana, University of Hull [United Kingdom], Castle Hill Hospital, Institute of Cardiovascular and Medical Sciences [Glasgow], University of Glasgow, CIBERCV, Carlos III Institute of Health, Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Universidad de Navarra [Pamplona] (UNAV), Clínica Universidad de Navarra [Pamplona], Netherlands Heart Institute, Partenaires INRAE, Leiden University Medical Center (LUMC), Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 (RID-AGE), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Université de Lille-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Fraunhofer Institute for Toxicology and Experimental Medicine (Fraunhofer ITEM), Fraunhofer (Fraunhofer-Gesellschaft), Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université de Paris (UP), Marqueurs cardiovasculaires en situation de stress (MASCOT (UMR_S_942 / U942)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP)-Université Sorbonne Paris Nord, University Medical Center Groningen [Groningen] (UMCG), Non-Profit Research Institute Alliance for the Promotion of Preventive Medicine, Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing, Royal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute [London] (NHLI), Imperial College London-Royal Brompton and Harefield NHS Foundation Trust, The research leading to these results has received funding from the European Union Commission's Seventh Framework Programme under grant agreement 305507 [HOMAGE (Heart Omics in Ageing consortium)]. We acknowledge the support from the Netherlands Cardiovascular Research Initiative, an initiative with the support of the Dutch Heart Foundation CVON2016-Early HFPEF, and CVON 2017-21, SHE-PREDICTS-HF. JPF, NG, PR, and FZ are supported by the Contrat de Plan Etat-Lorraine and FEDER Lorraine, and a public grant overseen by the French National Research Agency (ANR) as part of the second 'Investissements d'Avenir' programme FIGHT-HF (reference: ANR-15-RHU-0004) and by the French PIA project 'Lorraine Université d'Excellence', reference ANR-15-IDEX-04-LUE. They thank the CRB lorrain for biobaking activities. JAS is supported by the Non-Profit Research Institute Alliance for the Promotion of Preventive Medicine (URL: http://www.appremed.orgTest), Mechelen, Belgium received a non-binding research grant from OMRON Healthcare Co., Ltd., Kyoto, Japan., ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE,Isite LUE(2015), European Project: 305507, Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Universiteit Leiden, Université Paris Cité (UPCité), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, Cardiologie, RS: Carim - H02 Cardiomyopathy, MUMC+: DA KG Lab Centraal Lab (9), MUMC+: MA Med Staf Spec Cardiologie (9), MUMC+: MA Med Staf Artsass Cardiologie (9), Cardiovascular Centre (CVC), BOZEC, Erwan, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID, ISITE - Isite LUE - - LUE2015 - ANR-15-IDEX-0004 - IDEX - VALID, HOMAGE (Heart Omics in Ageing consortium) - 305507 - INCOMING, Publica

المصدر: ESC Heart Failure, Vol 8, Iss 5, Pp 3512-3520 (2021)
ESC Heart Failure, 8(5), 3512-3520. WILEY PERIODICALS, INC
ESC Heart Failure
ESC Heart Failure, Wiley, 2021, ⟨10.1002/ehf2.13476⟩
ESC Heart Failure, 2021, ⟨10.1002/ehf2.13476⟩
Esc heart failure, 8(5), 3512-3520. John Wiley & Sons Inc.

مصطلحات موضوعية: Male, Proteomics, Cardiac & Cardiovascular Systems, Disease, 030204 cardiovascular system & hematology, Cohort Studies, 0302 clinical medicine, DESIGN, Original Research Articles, Medicine, Original Research Article, 030212 general & internal medicine, ASSOCIATIONS, RISK, Sex Characteristics, WOMEN, Pathophysiology, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, Cohort, Biomarker (medicine), Female, ADIPOSITY, HORMONES, Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, medicine.medical_specialty, Incident heart failure, New onset, 03 medical and health sciences, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Sex differences, Humans, Diseases of the circulatory (Cardiovascular) system, ANTAGONIST, Heart Failure, Science & Technology, business.industry, INTERLEUKIN-17, medicine.disease, GENE, Interleukin 1 receptor antagonist, Case-Control Studies, Heart failure, RC666-701, Cardiovascular System & Cardiology, IL17A, business, Biomarkers

وصف الملف: application/pdf; Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a70a1a6189d196040b6f8d7f3b7e7e6Test
https://doaj.org/article/a0903e2857b544a9b4e4d1d58030724bTest

المؤلفون: Gerasimos Filippatos, João Pedro Ferreira, Anne Pernille Ofstad, Waheed Jamal, Christoph Wanner, Javed Butler, Elke Schüler, Martina Brueckmann, Investigators, Stuart J. Pocock, Milton Packer, Faiez Zannad, EMPEROR-Reduced Trial Committees, Piotr Ponikowski, Stefan D. Anker, Michael Böhm, Felix Mahfoud

المساهمون: Saarland University [Saarbrücken], Berlin Institute of Health Center for Regenerative Therapies, German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], University of Mississippi Medical Center (UMMC), National and Kapodistrian University of Athens (NKUA), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), London School of Hygiene and Tropical Medicine (LSHTM), Boehringer Ingelheim International GmbH, University of Heidelberg, Medical Faculty, Boehringer Ingelheim Norway KS, mainanalytics GmbH, Wroclaw Medical University, University Hospital of Würzburg, Baylor University Medical Center, Baylor College of Medecine, Imperial College London, BOZEC, Erwan, Wrocław Medical University

المصدر: Journal of the American College of Cardiology
Journal of the American College of Cardiology, Elsevier, 2021, 78 (13), pp.1337-1348. ⟨10.1016/j.jacc.2021.07.049⟩

مصطلحات موضوعية: Male, systolic blood pressure, medicine.medical_specialty, animal structures, empagliflozin, heart failure, Blood Pressure, 030204 cardiovascular system & hematology, Cardiovascular death, 03 medical and health sciences, 0302 clinical medicine, Glucosides, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Empagliflozin, medicine, Humans, In patient, 030212 general & internal medicine, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, Ejection fraction, business.industry, kidney outcomes, Middle Aged, medicine.disease, cardiovascular outcomes, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, Treatment Outcome, Blood pressure, Heart failure, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, Cardiovascular outcomes, Glomerular Filtration Rate, Heart Failure, Systolic

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b96fc9228db16a615cd8317bfd0a6654Test
https://doi.org/10.1016/j.jacc.2021.07.049Test

المؤلفون: João Pedro Ferreira, Abhinav Sharma, Faiez Zannad

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Division of Cardiology, McGill University Health Centre, McGill University, BOZEC, Erwan

المصدر: The American Journal of Medicine
The American Journal of Medicine, Elsevier [Commercial Publisher] 2021, 134 (5), pp.569-575. ⟨10.1016/j.amjmed.2020.11.007⟩

مصطلحات موضوعية: Meat, Health impact, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Environmental health, Humans, Medicine, Environmental impact assessment, 030212 general & internal medicine, Randomized Controlled Trials as Topic, Consumption (economics), Health consequences, business.industry, Diet, Vegetarian, food and beverages, General Medicine, Evidence-based medicine, Diet, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Agriculture, Resource use, business, Health impact assessment, Forecasting

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63a37606b9c07bcb2a593f494354923dTest
https://doi.org/10.1016/j.amjmed.2020.11.007Test

المؤلفون: Martina Brueckmann, Stuart J. Pocock, Javed Butler, Michele Senni, Piotr Ponikowski, Subodh Verma, Tariq Jamal Siddiqi, Ileana L. Piña, Faiez Zannad, James L. Januzzi, Michael Böhm, Sanjay Kaul, Ola Vedin, Vijay K. Chopra, Stefan D. Anker, João Pedro Ferreira, Sanjiv J. Shah, Barbara Peil, Gerasimos Filippatos, Milton Packer

المساهمون: BOZEC, Erwan, University of Mississippi Medical Center (UMMC), National and Kapodistrian University of Athens (NKUA), University of Athens, Attikon Hospital, Boehringer Ingelheim International GmbH, Saarland University [Saarbrücken], Max Superspeciality Hospital, Saket, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Massachusetts General Hospital [Boston], Baim Institute for Clinical Research Boston MA, Cedars-Sinai Medical Center, Central Michigan University, Mount Pleasant, Wrocław Medical University, Northwestern University Feinberg School of Medicine, Cardiovascular Department, Cardiology Division, Papa Giovanni XXIII Hospital, Boehringer Ingelheim AB, Stockholm, Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Boehringer Ingelheim Pharma GmbH & Co, Department of Medical Statistics, London School of Hygiene & Tropical Medicine, Cardiovascular Science, Baylor Heart and Vascular Institute, Baylor University Medical Center, Imperial College London, Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, The EMPEROR-Preserved trial was supported by Boehringer Ingelheim and Eli Lilly and Company, Wroclaw Medical University [Wrocław, Pologne], Butler, J, Filippatos, G, Jamal Siddiqi, T, Brueckmann, M, Bohm, M, Chopra, V, Pedro Ferreira, J, Januzzi, J, Kaul, S, Pina, I, Ponikowski, P, Shah, S, Senni, M, Vedin, O, Verma, S, Peil, B, Pocock, S, Zannad, F, Packer, M, Anker, S

المصدر: Circulation
Circulation, American Heart Association, 2021, ⟨10.1161/CIRCULATIONAHA.121.057812⟩

مصطلحات موضوعية: Male, medicine.medical_specialty, Health Status, empagliflozin, health statu, 030204 cardiovascular system & hematology, Placebo, Total symptom score, Ventricular Function, Left, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Quality of life, Glucosides, Physiology (medical), Internal medicine, medicine, Empagliflozin, Humans, In patient, 030212 general & internal medicine, Benzhydryl Compounds, Aged, Aged, 80 and over, Heart Failure, Ejection fraction, business.industry, Stroke Volume, Middle Aged, medicine.disease, humanities, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, diastolic, Kansas City Cardiomyopathy Questionnaire, Heart failure, Cardiology, Quality of Life, Female, Cardiology and Cardiovascular Medicine, business

وصف الملف: application/pdf; STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37aa4afda2fffc278b8699f3997d1edcTest
https://pubmed.ncbi.nlm.nih.gov/35445788Test

المؤلفون: Abhinav Sharma, Faiez Zannad, João Pedro Ferreira, Xavier Rossello, Cyrus R. Mehta, George L. Bakris, Francisca Caimari, Zohra Lamiral, William B. White, Christopher P. Cannon

المصدر: Clinical Research in Cardiology. 110:1612-1624

مصطلحات موضوعية: medicine.medical_specialty, Acute coronary syndrome, business.industry, Proportional hazards model, General Medicine, Type 2 diabetes, 030204 cardiovascular system & hematology, medicine.disease, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Heart failure, Cohort, Cardiology, Medicine, 030212 general & internal medicine, Myocardial infarction, Cardiology and Cardiovascular Medicine, business, Mace

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d7f8c497b9b6c995d5f1c336c832ca8cTest
https://doi.org/10.1007/s00392-021-01859-2Test

المؤلفون: Pierpaolo Pellicori, Blerim Mujaj, Stephane Heymans, Fozia Z Ahmed, N. Girerd, Ping Wang, Arantxa González, Hans-Peter Brunner-La-Rocca, Javier Díez, Franco Cosmi, Frank T. Edelmann, Mark R. Hazebroek, João Pedro Ferreira, Joe Cuthbert, Andrew L. Clark, Johannes Petutschnigg, Mamas A. Mamas, Roberto Latini, Job A J Verdonschot, John G.F. Cleland, Beatrice Mariottoni, Patrick Rossignol, Javed Khan, Jan A. Staessen, Burkert Pieske, Faiez Zannad, Anne Pizard, Stéphanie Grojean, Timothy Collier, Philippe Rouet

المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], London School of Hygiene and Tropical Medicine (LSHTM), University of Manchester [Manchester], University of Hull [United Kingdom], Cortona Hospital, Universidad de Navarra [Pamplona] (UNAV), German Heart Institute Berlin, University of Glasgow, Mario Negri Institute, Center for Human Genetics, University of Leuven School of Medicine, SCHOOL of MEDICINE [Louvain], Université Catholique de Louvain = Catholic University of Louvain (UCL)-Université Catholique de Louvain = Catholic University of Louvain (UCL), Centre d'anthropologie et de génomique de Toulouse (CAGT), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), Author Disclosures HOMAGE was funded by a grant from the European Union 7th Framework Programme for Research and Technological Development (HEALTH-F7-305507 HOMAGE (EU FP7 305507 http://www.homage-hf.euTest). Drs. Ferreira, Rossignol, Girerd, and Zannad are supported by the RHU Fight-HF, a public grant overseen by the French National Research Agency (ANR) as part of the second 'Investissements d’Avenir' program (reference: ANR-15-RHUS-0004), the French PIA project 'Lorraine Université d’Excellence' (reference: ANR-15-IDEX-04-LUE), Contrat de Plan Etat Lorraine IT2MP, and FEDER Lorraine. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE,Isite LUE(2015), European Project: 305507,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,HOMAGE(2013), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), DE CARVALHO, Philippe, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID, ISITE - Isite LUE - - LUE2015 - ANR-15-IDEX-0004 - IDEX - VALID, Heart OMics in AGEing - HOMAGE - - EC:FP7:HEALTH2013-02-01 - 2019-01-31 - 305507 - VALID, RS: Carim - H02 Cardiomyopathy, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), MUMC+: MA Med Staf Artsass Cardiologie (9)

المصدر: JACC: Heart Failure
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD

مصطلحات موضوعية: Male, Proteomics, [SDV]Life Sciences [q-bio], Adipokine, Inflammation, 030204 cardiovascular system & hematology, Pharmacology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Mineralocorticoid receptor, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Fibrosis, Renin–angiotensin system, Natriuretic Peptide, Brain, medicine, Humans, 030212 general & internal medicine, Aged, Mineralocorticoid Receptor Antagonists, Heart Failure, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, business.industry, fibrosis, spironolactone, HEART-FAILURE INSIGHTS, medicine.disease, Brain natriuretic peptide, 3. Good health, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, CARDIAC MATRIX BIOMARKERS, [SDV] Life Sciences [q-bio], renin-angiotensin-aldosterone system, chemistry, MYOCARDIAL-INFARCTION, inflammation, Heart failure, Spironolactone, SURVIVAL, EPLERENONE, Female, medicine.symptom, Cardiology and Cardiovascular Medicine, business, heart failure prevention, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff2f9ef636912f7d1efd60c7c971fbe4Test
https://cris.maastrichtuniversity.nl/en/publications/f2280d92-dac9-4b92-a4fa-39b9afb82d38Test

المؤلفون: Faiez Zannad, Laura Filipetti, Erwan Bozec, Masatake Kobayashi, Christine Selton-Suty, Stefano Coiro, Zohra Lamiral, Patrick Rossignol, João Pedro Ferreira, Nicolas Girerd, Olivier Huttin

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Service de Cardiologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Division of Cardiology, University of Perugia, Ospedale S. Maria della Misericordia, The STANISLAS study was sponsored by Nancy CHRU and supported by a public grant overseen by the French National Research Agency (ANR) as part of the second ‘Investissements d'Avenir’ programme (reference: ANR‐15‐RHUS‐0004). The BioSE‐PreIC study was funded by the 'programme hospitalier de recherche clinique' (PHRCI 13‐084), ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), Università degli Studi di Perugia = University of Perugia (UNIPG), BOZEC, Erwan, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID

المصدر: ESC Heart Failure
ESC Heart Failure, Wiley, 2021, ⟨10.1002/ehf2.13203⟩
ESC Heart Failure, Vol 8, Iss 2, Pp 1700-1705 (2021)
ESC Heart Failure, 2021, ⟨10.1002/ehf2.13203⟩

مصطلحات موضوعية: Male, Proteomics, lcsh:Diseases of the circulatory (Cardiovascular) system, medicine.medical_specialty, Short Communication, Short Communications, Diastole, Heart failure, 030204 cardiovascular system & hematology, Doppler echocardiography, Left ventricular hypertrophy, 03 medical and health sciences, Procollagen type III, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Natriuretic Peptide, Brain, medicine, Humans, cardiovascular diseases, 030212 general & internal medicine, Heart failure, diastolic, Ventricular Remodeling, medicine.diagnostic_test, business.industry, Systolic function, Doppler, Left ventricle, medicine.disease, Brain natriuretic peptide, Predictive value, Echocardiography, Doppler, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, diastolic, lcsh:RC666-701, Echocardiography, Cohort, Cardiology, Female, Hypertrophy, Left Ventricular, Collagen, Cardiomyopathies, Cardiology and Cardiovascular Medicine, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e694870e326b2de68ec27e5018389cfeTest
https://doi.org/10.1002/ehf2.13203Test